EUVIMEDEUVIMED entdecken
Crossref

Noninvasive Monitoring of Immunotherapy in Lung Cancer by Lymphocyte Activation Gene 3 PET Imaging of Tumor-Infiltrating Lymphocytes

Zhen Quan, Zhaoguo Han, Yang Yang, Jiannan Wang, Hui Wang, Lili Yang, Rong A, Xinxin Hu, Jing Wang, Xiaona Li, Xiaoqian Li, Hong Yu und 3 weitere

Journal of Nuclear Medicine · 2024-01 · 65 (1) · 25-32

DOI: 10.2967/jnumed.123.266002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 16.11.2023. Verfasst von Zhen Quan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungHumansMiceAnimalsGallium RadioisotopesLymphocytes, Tumor-InfiltratingLymphocyte ActivationPositron-Emission TomographyImmunotherapyCell Line, Tumor

Stichwörter der Autor:innen

LAG-3PETTILimmunotherapylung cancer

Substanzen

Gallium Radioisotopes

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  • NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Molecular Imaging Research Center (MIRC) of Harbin Medical University, Harbin, Heilongjiang, China.
  • Biomedical Research Imaging Center (BRIC), The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China; and.
  • Department of Nuclear Medicine and Laboratory of Clinical Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Department of Nuclear Medicine, Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, China; sunxl@ems.hrbmu.edu.cn.

Zitieren

APA

Quan, Z., Han, Z., Yang, Y., Wang, J., Wang, H., Yang, L., A, R., Hu, X., Wang, J., Li, X., Li, X., Yu, H., Chen, W., Wang, K., & Sun, X. (2024). Noninvasive Monitoring of Immunotherapy in Lung Cancer by Lymphocyte Activation Gene 3 PET Imaging of Tumor-Infiltrating Lymphocytes. Journal of Nuclear Medicine, 65(1), 25-32. https://doi.org/10.2967/jnumed.123.266002

Vancouver

Quan Z, Han Z, Yang Y, Wang J, Wang H, Yang L, et al. Noninvasive Monitoring of Immunotherapy in Lung Cancer by Lymphocyte Activation Gene 3 PET Imaging of Tumor-Infiltrating Lymphocytes. Journal of Nuclear Medicine. 2024;65(1):25-32. doi:10.2967/jnumed.123.266002

BibTeX
@article{Quan2024,
  author = {Quan, Zhen and Han, Zhaoguo and Yang, Yang and Wang, Jiannan and Wang, Hui and Yang, Lili and A, Rong and Hu, Xinxin and Wang, Jing and Li, Xiaona and Li, Xiaoqian and Yu, Hong and Chen, Wei and Wang, Kai and Sun, Xilin},
  title = {Noninvasive Monitoring of Immunotherapy in Lung Cancer by Lymphocyte Activation Gene 3 PET Imaging of Tumor-Infiltrating Lymphocytes},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  volume = {65},
  number = {1},
  pages = {25--32},
  doi = {10.2967/jnumed.123.266002}
}
Kostenlos starten →